142 related articles for article (PubMed ID: 33910968)
1. Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal Activity.
Traczewski MM; Ambler JE; Schuch R
J Clin Microbiol; 2021 Jun; 59(7):e0311720. PubMed ID: 33910968
[TBL] [Abstract][Full Text] [Related]
2. Development of a Broth Microdilution Method for Exebacase Susceptibility Testing.
Oh JT; Ambler JE; Cassino C; Schuch R
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0258720. PubMed ID: 33903102
[TBL] [Abstract][Full Text] [Related]
3. Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin.
Miller AA; Traczewski MM; Huband MD; Bradford PA; Mueller JP
J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31315953
[TBL] [Abstract][Full Text] [Related]
4. Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide.
Hackel MA; Karlowsky JA; Dressel D; Sahm DF
J Clin Microbiol; 2017 Oct; 55(10):3021-3027. PubMed ID: 28747372
[TBL] [Abstract][Full Text] [Related]
5. The Lysin Exebacase Has a Low Propensity for Resistance Development in Staphylococcus aureus and Suppresses the Emergence of Resistance to Antistaphylococcal Antibiotics.
Oh J; Warner M; Ambler JE; Schuch R
Microbiol Spectr; 2023 Mar; 11(2):e0526122. PubMed ID: 36862002
[TBL] [Abstract][Full Text] [Related]
6. Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor Enmetazobactam.
Belley A; Huband MD; Fedler KA; Watters AA; Flamm RK; Shapiro S; Knechtle P
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167844
[TBL] [Abstract][Full Text] [Related]
7. Exebacase Is Active
Swift SM; Sauve K; Cassino C; Schuch R
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0272320. PubMed ID: 34228536
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Activity of Exebacase (Lysin CF-301) against the Most Common Causes of Infective Endocarditis.
Watson A; Oh JT; Sauve K; Bradford PA; Cassino C; Schuch R
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332073
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of Exebacase (CF-301) against clinical Staphylococcus aureus surveillance isolates from the United States, Europe, and Latin America, 2015-2017.
Traczewski M; Oh J; Cassino C; Schuch R
Diagn Microbiol Infect Dis; 2019 Dec; 95(4):114879. PubMed ID: 31466875
[TBL] [Abstract][Full Text] [Related]
10. Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).
Fowler VG; Das AF; Lipka-Diamond J; Ambler JE; Schuch R; Pomerantz R; Cassino C; Jáuregui-Peredo L; Moran GJ; Rupp ME; Lachiewicz AM; Kuti JL; Wise RA; Kaye KS; Zervos MJ; Nichols WG
Clin Infect Dis; 2024 Jun; 78(6):1473-1481. PubMed ID: 38297916
[TBL] [Abstract][Full Text] [Related]
11. Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters.
Arhin FF; Tomfohrde K; Draghi DC; Aranza M; Parr TR; Sahm DF; Moeck G
Diagn Microbiol Infect Dis; 2008 Sep; 62(1):92-5. PubMed ID: 18614315
[TBL] [Abstract][Full Text] [Related]
12. Postantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity against Staphylococcus aureus.
Oh JT; Cassino C; Schuch R
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936103
[TBL] [Abstract][Full Text] [Related]
13. Determination of MIC Quality Control Ranges for Ceftibuten-Avibactam (Fixed 4 μg/mL), a Novel β-Lactam/β-Lactamase Inhibitor Combination.
Huband MD; Fedler KA; Sader HS; Stone GG; Castanheira M
J Clin Microbiol; 2023 Jul; 61(7):e0165722. PubMed ID: 37395644
[TBL] [Abstract][Full Text] [Related]
14. Quality control MIC ranges used for telavancin with application of a revised CLSI reference broth microdilution method.
Ross JE; Mendes RE; Jones RN
J Clin Microbiol; 2014 Sep; 52(9):3399-401. PubMed ID: 24920777
[TBL] [Abstract][Full Text] [Related]
15. Quality control ranges for testing broth microdilution susceptibility of Flavobacterium columnare and F. psychrophilum to nine antimicrobials.
Gieseker CM; Mayer TD; Crosby TC; Carson J; Dalsgaard I; Darwish AM; Gaunt PS; Gao DX; Hsu HM; Lin TL; Oaks JL; Pyecroft M; Teitzel C; Somsiri T; Wu CC
Dis Aquat Organ; 2012 Nov; 101(3):207-15. PubMed ID: 23324417
[TBL] [Abstract][Full Text] [Related]
16. Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinone.
Anderegg TR; Jones RN;
Diagn Microbiol Infect Dis; 2003 Jan; 45(1):73-6. PubMed ID: 12573554
[TBL] [Abstract][Full Text] [Related]
17. A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid.
Kaniga K; Cirillo DM; Hoffner S; Ismail NA; Kaur D; Lounis N; Metchock B; Pfyffer GE; Venter A
J Clin Microbiol; 2016 Dec; 54(12):2963-2968. PubMed ID: 27654338
[TBL] [Abstract][Full Text] [Related]
18. Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.
Odland BA; Erwin ME; Jones RN
J Clin Microbiol; 2000 Jan; 38(1):453-5. PubMed ID: 10618141
[TBL] [Abstract][Full Text] [Related]
19. A Multilaboratory, Multicountry Study To Determine Bedaquiline MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing.
Kaniga K; Cirillo DM; Hoffner S; Ismail NA; Kaur D; Lounis N; Metchock B; Pfyffer GE; Venter A
J Clin Microbiol; 2016 Dec; 54(12):2956-2962. PubMed ID: 27654337
[TBL] [Abstract][Full Text] [Related]
20. Establishing quality control ranges for antimicrobial susceptibility testing of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus: a cornerstone to develop reference strains for Korean clinical microbiology laboratories.
Hong SK; Choi SJ; Shin S; Lee W; Pinto N; Shin N; Lee K; Hong SG; Kim YA; Lee H; Kim H; Song W; Lee SH; Yong D; Lee K; Chong Y
Ann Lab Med; 2015 Nov; 35(6):635-8. PubMed ID: 26354353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
